Targeting <scp>EP</scp>4 downstream c‐Jun through <scp>ERK</scp>1/2‐mediated reduction of <scp>DNMT</scp>1 reveals novel mechanism of solamargine‐inhibited growth of lung cancer cells
Journal of Cellular and Molecular Medicine